Global Macitentan Tablets Market Growth 2026-2032
The global Macitentan Tablets market size is predicted to grow from US$ 2162 million in 2025 to US$ 4544 million in 2032; it is expected to grow at a CAGR of 11.4% from 2026 to 2032.
Macitentan is currently the only ERA drug that has conclusive research evidence to support its ability to delay right ventricular remodeling. It is also the only ERA drug that currently has research data to support that a single drug can significantly reduce the risk of patient deterioration or death by 55%.
7. ERA drugs--ERA Drugs--ERA drugs (Endothelin Receptor Antagonists) are a class of drugs used to treat certain cardiovascular and pulmonary diseases. They relax blood vessels, lower blood pressure and improve blood flow by blocking the binding of endothelin, a potent vasoconstrictor, to its receptors.
United States market for Macitentan Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Macitentan Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Macitentan Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Macitentan Tablets players cover Johnson & Johnson, Zhengda Tianqing, Sinotherapeutics, Qilu Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Macitentan Tablets Industry Forecast? looks at past sales and reviews total world Macitentan Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Macitentan Tablets sales for 2026 through 2032. With Macitentan Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Macitentan Tablets industry.
This Insight Report provides a comprehensive analysis of the global Macitentan Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Macitentan Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Macitentan Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Macitentan Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Macitentan Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Macitentan Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Macitentan Tablets market?
What factors are driving Macitentan Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Macitentan Tablets market opportunities vary by end market size?
How does Macitentan Tablets break out by Type, by Application?
Macitentan is currently the only ERA drug that has conclusive research evidence to support its ability to delay right ventricular remodeling. It is also the only ERA drug that currently has research data to support that a single drug can significantly reduce the risk of patient deterioration or death by 55%.
7. ERA drugs--ERA Drugs--ERA drugs (Endothelin Receptor Antagonists) are a class of drugs used to treat certain cardiovascular and pulmonary diseases. They relax blood vessels, lower blood pressure and improve blood flow by blocking the binding of endothelin, a potent vasoconstrictor, to its receptors.
United States market for Macitentan Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Macitentan Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Macitentan Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Macitentan Tablets players cover Johnson & Johnson, Zhengda Tianqing, Sinotherapeutics, Qilu Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Macitentan Tablets Industry Forecast? looks at past sales and reviews total world Macitentan Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Macitentan Tablets sales for 2026 through 2032. With Macitentan Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Macitentan Tablets industry.
This Insight Report provides a comprehensive analysis of the global Macitentan Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Macitentan Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Macitentan Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Macitentan Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Macitentan Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Macitentan Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Original Drug
- Generic Drug
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson
- Zhengda Tianqing
- Sinotherapeutics
- Qilu Pharmaceutical
- Hangzhou Zhongmei Huadong Pharmaceutical
- Shanghai Xudong Haipu Pharmaceutical
- Shanghai Pharmaceutical Group
- Jiangsu Yunyang Group Pharmaceutical
- Mylan
- Teva
- Dr. Reddy's Laboratories
What is the 10-year outlook for the global Macitentan Tablets market?
What factors are driving Macitentan Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Macitentan Tablets market opportunities vary by end market size?
How does Macitentan Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Macitentan Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Macitentan Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Macitentan Tablets by Country/Region, 2021, 2025 & 2032
2.2 Macitentan Tablets Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.2.3 Macitentan Tablets Sales by Type
2.2.3.1 Global Macitentan Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Macitentan Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Macitentan Tablets Sale Price by Type (2021-2026)
2.3 Macitentan Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Macitentan Tablets Sales by Application
2.3.4.1 Global Macitentan Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Macitentan Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Macitentan Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Macitentan Tablets Breakdown Data by Company
3.1.1 Global Macitentan Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Macitentan Tablets Sales Market Share by Company (2021-2026)
3.2 Global Macitentan Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Macitentan Tablets Revenue by Company (2021-2026)
3.2.2 Global Macitentan Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Macitentan Tablets Sale Price by Company
3.4 Key Manufacturers Macitentan Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Macitentan Tablets Product Location Distribution
3.4.2 Players Macitentan Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MACITENTAN TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Macitentan Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Macitentan Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Macitentan Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Macitentan Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Macitentan Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Macitentan Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Macitentan Tablets Sales Growth
4.4 APAC Macitentan Tablets Sales Growth
4.5 Europe Macitentan Tablets Sales Growth
4.6 Middle East & Africa Macitentan Tablets Sales Growth
5 AMERICAS
5.1 Americas Macitentan Tablets Sales by Country
5.1.1 Americas Macitentan Tablets Sales by Country (2021-2026)
5.1.2 Americas Macitentan Tablets Revenue by Country (2021-2026)
5.2 Americas Macitentan Tablets Sales by Type (2021-2026)
5.3 Americas Macitentan Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Macitentan Tablets Sales by Region
6.1.1 APAC Macitentan Tablets Sales by Region (2021-2026)
6.1.2 APAC Macitentan Tablets Revenue by Region (2021-2026)
6.2 APAC Macitentan Tablets Sales by Type (2021-2026)
6.3 APAC Macitentan Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Macitentan Tablets by Country
7.1.1 Europe Macitentan Tablets Sales by Country (2021-2026)
7.1.2 Europe Macitentan Tablets Revenue by Country (2021-2026)
7.2 Europe Macitentan Tablets Sales by Type (2021-2026)
7.3 Europe Macitentan Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Macitentan Tablets by Country
8.1.1 Middle East & Africa Macitentan Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Macitentan Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Macitentan Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Macitentan Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Macitentan Tablets
10.3 Manufacturing Process Analysis of Macitentan Tablets
10.4 Industry Chain Structure of Macitentan Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Macitentan Tablets Distributors
11.3 Macitentan Tablets Customer
12 WORLD FORECAST REVIEW FOR MACITENTAN TABLETS BY GEOGRAPHIC REGION
12.1 Global Macitentan Tablets Market Size Forecast by Region
12.1.1 Global Macitentan Tablets Forecast by Region (2027-2032)
12.1.2 Global Macitentan Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Macitentan Tablets Forecast by Type (2027-2032)
12.7 Global Macitentan Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Macitentan Tablets Product Portfolios and Specifications
13.1.3 Johnson & Johnson Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Zhengda Tianqing
13.2.1 Zhengda Tianqing Company Information
13.2.2 Zhengda Tianqing Macitentan Tablets Product Portfolios and Specifications
13.2.3 Zhengda Tianqing Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Zhengda Tianqing Main Business Overview
13.2.5 Zhengda Tianqing Latest Developments
13.3 Sinotherapeutics
13.3.1 Sinotherapeutics Company Information
13.3.2 Sinotherapeutics Macitentan Tablets Product Portfolios and Specifications
13.3.3 Sinotherapeutics Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sinotherapeutics Main Business Overview
13.3.5 Sinotherapeutics Latest Developments
13.4 Qilu Pharmaceutical
13.4.1 Qilu Pharmaceutical Company Information
13.4.2 Qilu Pharmaceutical Macitentan Tablets Product Portfolios and Specifications
13.4.3 Qilu Pharmaceutical Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Qilu Pharmaceutical Main Business Overview
13.4.5 Qilu Pharmaceutical Latest Developments
13.5 Hangzhou Zhongmei Huadong Pharmaceutical
13.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
13.5.2 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Product Portfolios and Specifications
13.5.3 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Main Business Overview
13.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
13.6 Shanghai Xudong Haipu Pharmaceutical
13.6.1 Shanghai Xudong Haipu Pharmaceutical Company Information
13.6.2 Shanghai Xudong Haipu Pharmaceutical Macitentan Tablets Product Portfolios and Specifications
13.6.3 Shanghai Xudong Haipu Pharmaceutical Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Shanghai Xudong Haipu Pharmaceutical Main Business Overview
13.6.5 Shanghai Xudong Haipu Pharmaceutical Latest Developments
13.7 Shanghai Pharmaceutical Group
13.7.1 Shanghai Pharmaceutical Group Company Information
13.7.2 Shanghai Pharmaceutical Group Macitentan Tablets Product Portfolios and Specifications
13.7.3 Shanghai Pharmaceutical Group Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shanghai Pharmaceutical Group Main Business Overview
13.7.5 Shanghai Pharmaceutical Group Latest Developments
13.8 Jiangsu Yunyang Group Pharmaceutical
13.8.1 Jiangsu Yunyang Group Pharmaceutical Company Information
13.8.2 Jiangsu Yunyang Group Pharmaceutical Macitentan Tablets Product Portfolios and Specifications
13.8.3 Jiangsu Yunyang Group Pharmaceutical Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Jiangsu Yunyang Group Pharmaceutical Main Business Overview
13.8.5 Jiangsu Yunyang Group Pharmaceutical Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Macitentan Tablets Product Portfolios and Specifications
13.9.3 Mylan Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Teva
13.10.1 Teva Company Information
13.10.2 Teva Macitentan Tablets Product Portfolios and Specifications
13.10.3 Teva Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Teva Main Business Overview
13.10.5 Teva Latest Developments
13.11 Dr. Reddy's Laboratories
13.11.1 Dr. Reddy's Laboratories Company Information
13.11.2 Dr. Reddy's Laboratories Macitentan Tablets Product Portfolios and Specifications
13.11.3 Dr. Reddy's Laboratories Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Dr. Reddy's Laboratories Main Business Overview
13.11.5 Dr. Reddy's Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Macitentan Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Macitentan Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Macitentan Tablets by Country/Region, 2021, 2025 & 2032
2.2 Macitentan Tablets Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.2.3 Macitentan Tablets Sales by Type
2.2.3.1 Global Macitentan Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Macitentan Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Macitentan Tablets Sale Price by Type (2021-2026)
2.3 Macitentan Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Macitentan Tablets Sales by Application
2.3.4.1 Global Macitentan Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Macitentan Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Macitentan Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Macitentan Tablets Breakdown Data by Company
3.1.1 Global Macitentan Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Macitentan Tablets Sales Market Share by Company (2021-2026)
3.2 Global Macitentan Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Macitentan Tablets Revenue by Company (2021-2026)
3.2.2 Global Macitentan Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Macitentan Tablets Sale Price by Company
3.4 Key Manufacturers Macitentan Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Macitentan Tablets Product Location Distribution
3.4.2 Players Macitentan Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MACITENTAN TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Macitentan Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Macitentan Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Macitentan Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Macitentan Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Macitentan Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Macitentan Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Macitentan Tablets Sales Growth
4.4 APAC Macitentan Tablets Sales Growth
4.5 Europe Macitentan Tablets Sales Growth
4.6 Middle East & Africa Macitentan Tablets Sales Growth
5 AMERICAS
5.1 Americas Macitentan Tablets Sales by Country
5.1.1 Americas Macitentan Tablets Sales by Country (2021-2026)
5.1.2 Americas Macitentan Tablets Revenue by Country (2021-2026)
5.2 Americas Macitentan Tablets Sales by Type (2021-2026)
5.3 Americas Macitentan Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Macitentan Tablets Sales by Region
6.1.1 APAC Macitentan Tablets Sales by Region (2021-2026)
6.1.2 APAC Macitentan Tablets Revenue by Region (2021-2026)
6.2 APAC Macitentan Tablets Sales by Type (2021-2026)
6.3 APAC Macitentan Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Macitentan Tablets by Country
7.1.1 Europe Macitentan Tablets Sales by Country (2021-2026)
7.1.2 Europe Macitentan Tablets Revenue by Country (2021-2026)
7.2 Europe Macitentan Tablets Sales by Type (2021-2026)
7.3 Europe Macitentan Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Macitentan Tablets by Country
8.1.1 Middle East & Africa Macitentan Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Macitentan Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Macitentan Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Macitentan Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Macitentan Tablets
10.3 Manufacturing Process Analysis of Macitentan Tablets
10.4 Industry Chain Structure of Macitentan Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Macitentan Tablets Distributors
11.3 Macitentan Tablets Customer
12 WORLD FORECAST REVIEW FOR MACITENTAN TABLETS BY GEOGRAPHIC REGION
12.1 Global Macitentan Tablets Market Size Forecast by Region
12.1.1 Global Macitentan Tablets Forecast by Region (2027-2032)
12.1.2 Global Macitentan Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Macitentan Tablets Forecast by Type (2027-2032)
12.7 Global Macitentan Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Macitentan Tablets Product Portfolios and Specifications
13.1.3 Johnson & Johnson Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Zhengda Tianqing
13.2.1 Zhengda Tianqing Company Information
13.2.2 Zhengda Tianqing Macitentan Tablets Product Portfolios and Specifications
13.2.3 Zhengda Tianqing Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Zhengda Tianqing Main Business Overview
13.2.5 Zhengda Tianqing Latest Developments
13.3 Sinotherapeutics
13.3.1 Sinotherapeutics Company Information
13.3.2 Sinotherapeutics Macitentan Tablets Product Portfolios and Specifications
13.3.3 Sinotherapeutics Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sinotherapeutics Main Business Overview
13.3.5 Sinotherapeutics Latest Developments
13.4 Qilu Pharmaceutical
13.4.1 Qilu Pharmaceutical Company Information
13.4.2 Qilu Pharmaceutical Macitentan Tablets Product Portfolios and Specifications
13.4.3 Qilu Pharmaceutical Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Qilu Pharmaceutical Main Business Overview
13.4.5 Qilu Pharmaceutical Latest Developments
13.5 Hangzhou Zhongmei Huadong Pharmaceutical
13.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
13.5.2 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Product Portfolios and Specifications
13.5.3 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Main Business Overview
13.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
13.6 Shanghai Xudong Haipu Pharmaceutical
13.6.1 Shanghai Xudong Haipu Pharmaceutical Company Information
13.6.2 Shanghai Xudong Haipu Pharmaceutical Macitentan Tablets Product Portfolios and Specifications
13.6.3 Shanghai Xudong Haipu Pharmaceutical Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Shanghai Xudong Haipu Pharmaceutical Main Business Overview
13.6.5 Shanghai Xudong Haipu Pharmaceutical Latest Developments
13.7 Shanghai Pharmaceutical Group
13.7.1 Shanghai Pharmaceutical Group Company Information
13.7.2 Shanghai Pharmaceutical Group Macitentan Tablets Product Portfolios and Specifications
13.7.3 Shanghai Pharmaceutical Group Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shanghai Pharmaceutical Group Main Business Overview
13.7.5 Shanghai Pharmaceutical Group Latest Developments
13.8 Jiangsu Yunyang Group Pharmaceutical
13.8.1 Jiangsu Yunyang Group Pharmaceutical Company Information
13.8.2 Jiangsu Yunyang Group Pharmaceutical Macitentan Tablets Product Portfolios and Specifications
13.8.3 Jiangsu Yunyang Group Pharmaceutical Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Jiangsu Yunyang Group Pharmaceutical Main Business Overview
13.8.5 Jiangsu Yunyang Group Pharmaceutical Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Macitentan Tablets Product Portfolios and Specifications
13.9.3 Mylan Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Teva
13.10.1 Teva Company Information
13.10.2 Teva Macitentan Tablets Product Portfolios and Specifications
13.10.3 Teva Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Teva Main Business Overview
13.10.5 Teva Latest Developments
13.11 Dr. Reddy's Laboratories
13.11.1 Dr. Reddy's Laboratories Company Information
13.11.2 Dr. Reddy's Laboratories Macitentan Tablets Product Portfolios and Specifications
13.11.3 Dr. Reddy's Laboratories Macitentan Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Dr. Reddy's Laboratories Main Business Overview
13.11.5 Dr. Reddy's Laboratories Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. MacitentanTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. MacitentanTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global MacitentanTablets Sales by Type (2021-2026) & (K Units)
Table 6. Global MacitentanTablets Sales Market Share by Type (2021-2026)
Table 7. Global MacitentanTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global MacitentanTablets Revenue Market Share by Type (2021-2026)
Table 9. Global MacitentanTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global MacitentanTablets Sale by Application (2021-2026) & (K Units)
Table 11. Global MacitentanTablets Sale Market Share by Application (2021-2026)
Table 12. Global MacitentanTablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global MacitentanTablets Revenue Market Share by Application (2021-2026)
Table 14. Global MacitentanTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global MacitentanTablets Sales by Company (2021-2026) & (K Units)
Table 16. Global MacitentanTablets Sales Market Share by Company (2021-2026)
Table 17. Global MacitentanTablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global MacitentanTablets Revenue Market Share by Company (2021-2026)
Table 19. Global MacitentanTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers MacitentanTablets Producing Area Distribution and Sales Area
Table 21. Players MacitentanTablets Products Offered
Table 22. MacitentanTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global MacitentanTablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global MacitentanTablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global MacitentanTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global MacitentanTablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global MacitentanTablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global MacitentanTablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global MacitentanTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global MacitentanTablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas MacitentanTablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas MacitentanTablets Sales Market Share by Country (2021-2026)
Table 35. Americas MacitentanTablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas MacitentanTablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas MacitentanTablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC MacitentanTablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC MacitentanTablets Sales Market Share by Region (2021-2026)
Table 40. APAC MacitentanTablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC MacitentanTablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC MacitentanTablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe MacitentanTablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe MacitentanTablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe MacitentanTablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe MacitentanTablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa MacitentanTablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa MacitentanTablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa MacitentanTablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa MacitentanTablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of MacitentanTablets
Table 52. Key Market Challenges & Risks of MacitentanTablets
Table 53. Key Industry Trends of MacitentanTablets
Table 54. MacitentanTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. MacitentanTablets Distributors List
Table 57. MacitentanTablets Customer List
Table 58. Global MacitentanTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global MacitentanTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas MacitentanTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas MacitentanTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC MacitentanTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC MacitentanTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe MacitentanTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe MacitentanTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa MacitentanTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa MacitentanTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global MacitentanTablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global MacitentanTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global MacitentanTablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global MacitentanTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Johnson & Johnson Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Johnson & Johnson MacitentanTablets Product Portfolios and Specifications
Table 74. Johnson & Johnson MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Latest Developments
Table 77. Zhengda Tianqing Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Zhengda Tianqing MacitentanTablets Product Portfolios and Specifications
Table 79. Zhengda Tianqing MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Zhengda Tianqing Main Business
Table 81. Zhengda Tianqing Latest Developments
Table 82. Sinotherapeutics Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Sinotherapeutics MacitentanTablets Product Portfolios and Specifications
Table 84. Sinotherapeutics MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sinotherapeutics Main Business
Table 86. Sinotherapeutics Latest Developments
Table 87. Qilu Pharmaceutical Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Qilu Pharmaceutical MacitentanTablets Product Portfolios and Specifications
Table 89. Qilu Pharmaceutical MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Qilu Pharmaceutical Main Business
Table 91. Qilu Pharmaceutical Latest Developments
Table 92. Hangzhou Zhongmei Huadong Pharmaceutical Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Hangzhou Zhongmei Huadong Pharmaceutical MacitentanTablets Product Portfolios and Specifications
Table 94. Hangzhou Zhongmei Huadong Pharmaceutical MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Hangzhou Zhongmei Huadong Pharmaceutical Main Business
Table 96. Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
Table 97. Shanghai Xudong Haipu Pharmaceutical Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Shanghai Xudong Haipu Pharmaceutical MacitentanTablets Product Portfolios and Specifications
Table 99. Shanghai Xudong Haipu Pharmaceutical MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Shanghai Xudong Haipu Pharmaceutical Main Business
Table 101. Shanghai Xudong Haipu Pharmaceutical Latest Developments
Table 102. Shanghai Pharmaceutical Group Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai Pharmaceutical Group MacitentanTablets Product Portfolios and Specifications
Table 104. Shanghai Pharmaceutical Group MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Shanghai Pharmaceutical Group Main Business
Table 106. Shanghai Pharmaceutical Group Latest Developments
Table 107. Jiangsu Yunyang Group Pharmaceutical Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Jiangsu Yunyang Group Pharmaceutical MacitentanTablets Product Portfolios and Specifications
Table 109. Jiangsu Yunyang Group Pharmaceutical MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Jiangsu Yunyang Group Pharmaceutical Main Business
Table 111. Jiangsu Yunyang Group Pharmaceutical Latest Developments
Table 112. Mylan Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Mylan MacitentanTablets Product Portfolios and Specifications
Table 114. Mylan MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Mylan Main Business
Table 116. Mylan Latest Developments
Table 117. Teva Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Teva MacitentanTablets Product Portfolios and Specifications
Table 119. Teva MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Teva Main Business
Table 121. Teva Latest Developments
Table 122. Dr. Reddy's Laboratories Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 123. Dr. Reddy's Laboratories MacitentanTablets Product Portfolios and Specifications
Table 124. Dr. Reddy's Laboratories MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Dr. Reddy's Laboratories Main Business
Table 126. Dr. Reddy's Laboratories Latest Developments
Table 1. MacitentanTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. MacitentanTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global MacitentanTablets Sales by Type (2021-2026) & (K Units)
Table 6. Global MacitentanTablets Sales Market Share by Type (2021-2026)
Table 7. Global MacitentanTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global MacitentanTablets Revenue Market Share by Type (2021-2026)
Table 9. Global MacitentanTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global MacitentanTablets Sale by Application (2021-2026) & (K Units)
Table 11. Global MacitentanTablets Sale Market Share by Application (2021-2026)
Table 12. Global MacitentanTablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global MacitentanTablets Revenue Market Share by Application (2021-2026)
Table 14. Global MacitentanTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global MacitentanTablets Sales by Company (2021-2026) & (K Units)
Table 16. Global MacitentanTablets Sales Market Share by Company (2021-2026)
Table 17. Global MacitentanTablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global MacitentanTablets Revenue Market Share by Company (2021-2026)
Table 19. Global MacitentanTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers MacitentanTablets Producing Area Distribution and Sales Area
Table 21. Players MacitentanTablets Products Offered
Table 22. MacitentanTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global MacitentanTablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global MacitentanTablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global MacitentanTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global MacitentanTablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global MacitentanTablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global MacitentanTablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global MacitentanTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global MacitentanTablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas MacitentanTablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas MacitentanTablets Sales Market Share by Country (2021-2026)
Table 35. Americas MacitentanTablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas MacitentanTablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas MacitentanTablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC MacitentanTablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC MacitentanTablets Sales Market Share by Region (2021-2026)
Table 40. APAC MacitentanTablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC MacitentanTablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC MacitentanTablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe MacitentanTablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe MacitentanTablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe MacitentanTablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe MacitentanTablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa MacitentanTablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa MacitentanTablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa MacitentanTablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa MacitentanTablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of MacitentanTablets
Table 52. Key Market Challenges & Risks of MacitentanTablets
Table 53. Key Industry Trends of MacitentanTablets
Table 54. MacitentanTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. MacitentanTablets Distributors List
Table 57. MacitentanTablets Customer List
Table 58. Global MacitentanTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global MacitentanTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas MacitentanTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas MacitentanTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC MacitentanTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC MacitentanTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe MacitentanTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe MacitentanTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa MacitentanTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa MacitentanTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global MacitentanTablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global MacitentanTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global MacitentanTablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global MacitentanTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Johnson & Johnson Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Johnson & Johnson MacitentanTablets Product Portfolios and Specifications
Table 74. Johnson & Johnson MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Latest Developments
Table 77. Zhengda Tianqing Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Zhengda Tianqing MacitentanTablets Product Portfolios and Specifications
Table 79. Zhengda Tianqing MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Zhengda Tianqing Main Business
Table 81. Zhengda Tianqing Latest Developments
Table 82. Sinotherapeutics Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Sinotherapeutics MacitentanTablets Product Portfolios and Specifications
Table 84. Sinotherapeutics MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sinotherapeutics Main Business
Table 86. Sinotherapeutics Latest Developments
Table 87. Qilu Pharmaceutical Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Qilu Pharmaceutical MacitentanTablets Product Portfolios and Specifications
Table 89. Qilu Pharmaceutical MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Qilu Pharmaceutical Main Business
Table 91. Qilu Pharmaceutical Latest Developments
Table 92. Hangzhou Zhongmei Huadong Pharmaceutical Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Hangzhou Zhongmei Huadong Pharmaceutical MacitentanTablets Product Portfolios and Specifications
Table 94. Hangzhou Zhongmei Huadong Pharmaceutical MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Hangzhou Zhongmei Huadong Pharmaceutical Main Business
Table 96. Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
Table 97. Shanghai Xudong Haipu Pharmaceutical Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Shanghai Xudong Haipu Pharmaceutical MacitentanTablets Product Portfolios and Specifications
Table 99. Shanghai Xudong Haipu Pharmaceutical MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Shanghai Xudong Haipu Pharmaceutical Main Business
Table 101. Shanghai Xudong Haipu Pharmaceutical Latest Developments
Table 102. Shanghai Pharmaceutical Group Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai Pharmaceutical Group MacitentanTablets Product Portfolios and Specifications
Table 104. Shanghai Pharmaceutical Group MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Shanghai Pharmaceutical Group Main Business
Table 106. Shanghai Pharmaceutical Group Latest Developments
Table 107. Jiangsu Yunyang Group Pharmaceutical Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Jiangsu Yunyang Group Pharmaceutical MacitentanTablets Product Portfolios and Specifications
Table 109. Jiangsu Yunyang Group Pharmaceutical MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Jiangsu Yunyang Group Pharmaceutical Main Business
Table 111. Jiangsu Yunyang Group Pharmaceutical Latest Developments
Table 112. Mylan Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Mylan MacitentanTablets Product Portfolios and Specifications
Table 114. Mylan MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Mylan Main Business
Table 116. Mylan Latest Developments
Table 117. Teva Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Teva MacitentanTablets Product Portfolios and Specifications
Table 119. Teva MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Teva Main Business
Table 121. Teva Latest Developments
Table 122. Dr. Reddy's Laboratories Basic Information, MacitentanTablets Manufacturing Base, Sales Area and Its Competitors
Table 123. Dr. Reddy's Laboratories MacitentanTablets Product Portfolios and Specifications
Table 124. Dr. Reddy's Laboratories MacitentanTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Dr. Reddy's Laboratories Main Business
Table 126. Dr. Reddy's Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Picture of MacitentanTablets
Figure 2. MacitentanTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global MacitentanTablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global MacitentanTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. MacitentanTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. MacitentanTablets Sales Market Share by Country/Region (2025)
Figure 10. MacitentanTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Original Drug
Figure 12. Product Picture of Generic Drug
Figure 13. Global MacitentanTablets Sales Market Share by Type in 2026
Figure 14. Global MacitentanTablets Revenue Market Share by Type (2021-2026)
Figure 15. MacitentanTablets Consumed in Hospital
Figure 16. Global MacitentanTablets Market: Hospital (2021-2026) & (K Units)
Figure 17. MacitentanTablets Consumed in Clinic
Figure 18. Global MacitentanTablets Market: Clinic (2021-2026) & (K Units)
Figure 19. MacitentanTablets Consumed in Other
Figure 20. Global MacitentanTablets Market: Other (2021-2026) & (K Units)
Figure 21. Global MacitentanTablets Sale Market Share by Application (2025)
Figure 22. Global MacitentanTablets Revenue Market Share by Application in 2026
Figure 23. MacitentanTablets Sales by Company in 2026 (K Units)
Figure 24. Global MacitentanTablets Sales Market Share by Company in 2026
Figure 25. MacitentanTablets Revenue by Company in 2026 ($ millions)
Figure 26. Global MacitentanTablets Revenue Market Share by Company in 2026
Figure 27. Global MacitentanTablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global MacitentanTablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas MacitentanTablets Sales 2021-2026 (K Units)
Figure 30. Americas MacitentanTablets Revenue 2021-2026 ($ millions)
Figure 31. APAC MacitentanTablets Sales 2021-2026 (K Units)
Figure 32. APAC MacitentanTablets Revenue 2021-2026 ($ millions)
Figure 33. Europe MacitentanTablets Sales 2021-2026 (K Units)
Figure 34. Europe MacitentanTablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa MacitentanTablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa MacitentanTablets Revenue 2021-2026 ($ millions)
Figure 37. Americas MacitentanTablets Sales Market Share by Country in 2026
Figure 38. Americas MacitentanTablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas MacitentanTablets Sales Market Share by Type (2021-2026)
Figure 40. Americas MacitentanTablets Sales Market Share by Application (2021-2026)
Figure 41. United States MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC MacitentanTablets Sales Market Share by Region in 2026
Figure 46. APAC MacitentanTablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC MacitentanTablets Sales Market Share by Type (2021-2026)
Figure 48. APAC MacitentanTablets Sales Market Share by Application (2021-2026)
Figure 49. China MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe MacitentanTablets Sales Market Share by Country in 2026
Figure 57. Europe MacitentanTablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe MacitentanTablets Sales Market Share by Type (2021-2026)
Figure 59. Europe MacitentanTablets Sales Market Share by Application (2021-2026)
Figure 60. Germany MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa MacitentanTablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa MacitentanTablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa MacitentanTablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of MacitentanTablets in 2026
Figure 74. Manufacturing Process Analysis of MacitentanTablets
Figure 75. Industry Chain Structure of MacitentanTablets
Figure 76. Channels of Distribution
Figure 77. Global MacitentanTablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global MacitentanTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global MacitentanTablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global MacitentanTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global MacitentanTablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global MacitentanTablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of MacitentanTablets
Figure 2. MacitentanTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global MacitentanTablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global MacitentanTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. MacitentanTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. MacitentanTablets Sales Market Share by Country/Region (2025)
Figure 10. MacitentanTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Original Drug
Figure 12. Product Picture of Generic Drug
Figure 13. Global MacitentanTablets Sales Market Share by Type in 2026
Figure 14. Global MacitentanTablets Revenue Market Share by Type (2021-2026)
Figure 15. MacitentanTablets Consumed in Hospital
Figure 16. Global MacitentanTablets Market: Hospital (2021-2026) & (K Units)
Figure 17. MacitentanTablets Consumed in Clinic
Figure 18. Global MacitentanTablets Market: Clinic (2021-2026) & (K Units)
Figure 19. MacitentanTablets Consumed in Other
Figure 20. Global MacitentanTablets Market: Other (2021-2026) & (K Units)
Figure 21. Global MacitentanTablets Sale Market Share by Application (2025)
Figure 22. Global MacitentanTablets Revenue Market Share by Application in 2026
Figure 23. MacitentanTablets Sales by Company in 2026 (K Units)
Figure 24. Global MacitentanTablets Sales Market Share by Company in 2026
Figure 25. MacitentanTablets Revenue by Company in 2026 ($ millions)
Figure 26. Global MacitentanTablets Revenue Market Share by Company in 2026
Figure 27. Global MacitentanTablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global MacitentanTablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas MacitentanTablets Sales 2021-2026 (K Units)
Figure 30. Americas MacitentanTablets Revenue 2021-2026 ($ millions)
Figure 31. APAC MacitentanTablets Sales 2021-2026 (K Units)
Figure 32. APAC MacitentanTablets Revenue 2021-2026 ($ millions)
Figure 33. Europe MacitentanTablets Sales 2021-2026 (K Units)
Figure 34. Europe MacitentanTablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa MacitentanTablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa MacitentanTablets Revenue 2021-2026 ($ millions)
Figure 37. Americas MacitentanTablets Sales Market Share by Country in 2026
Figure 38. Americas MacitentanTablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas MacitentanTablets Sales Market Share by Type (2021-2026)
Figure 40. Americas MacitentanTablets Sales Market Share by Application (2021-2026)
Figure 41. United States MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC MacitentanTablets Sales Market Share by Region in 2026
Figure 46. APAC MacitentanTablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC MacitentanTablets Sales Market Share by Type (2021-2026)
Figure 48. APAC MacitentanTablets Sales Market Share by Application (2021-2026)
Figure 49. China MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe MacitentanTablets Sales Market Share by Country in 2026
Figure 57. Europe MacitentanTablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe MacitentanTablets Sales Market Share by Type (2021-2026)
Figure 59. Europe MacitentanTablets Sales Market Share by Application (2021-2026)
Figure 60. Germany MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa MacitentanTablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa MacitentanTablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa MacitentanTablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries MacitentanTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of MacitentanTablets in 2026
Figure 74. Manufacturing Process Analysis of MacitentanTablets
Figure 75. Industry Chain Structure of MacitentanTablets
Figure 76. Channels of Distribution
Figure 77. Global MacitentanTablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global MacitentanTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global MacitentanTablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global MacitentanTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global MacitentanTablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global MacitentanTablets Revenue Market Share Forecast by Application (2027-2032)
